TY - JOUR
T1 - Radioactive seed localization compared to wire localization in breast-conserving surgery
T2 - Initial 6-month experience
AU - Murphy, James O.
AU - Moo, Tracy Ann
AU - King, Tari A.
AU - Van Zee, Kimberly J.
AU - Villegas, Kristine A.
AU - Stempel, Michelle
AU - Eaton, Anne
AU - St. Germain, Jean M.
AU - Morris, Elizabeth
AU - Morrow, Monica
N1 - Funding Information:
ACKNOWLEDGMENT This study was presented in part as a poster at the 2013 Society of Surgical Oncology Annual Cancer Symposium, National Harbor, MD. March 7–9, 2013. This study was funded in part through the NIH/NCI Cancer Center Support Grant P30 CA008748.
PY - 2013
Y1 - 2013
N2 - Background. Wire localization (WL) of nonpalpable breast cancers on the day of surgery is uncomfortable for patients and impacts operating room efficiency. Radioactive seed localization (RSL) before the day of surgery avoids these disadvantages. In this study we compare outcomes of our initial 6-month experience with RSL to those with WL in the preceding 6 months. Methods. Lumpectomies for invasive or intraductal cancers localized with a single 125iodine seed (January-June 2012) were compared with those using 1 wire (July- December 2011). Surgeons and radiologists did not change. Positive and close margins were defined as tumor on ink and tumor B1 mm from ink, respectively. Demographic and clinical characteristics and outcomes were compared between RSL and WL patients. Results. There were 431 RSL and 256 WL lumpectomies performed. Clinicopathologic characteristics did not differ between groups. Most seeds (90 %) were placed before the day of surgery. Positive margins were present in 7.7 % of RSL versus 5.5 % of WL patients, and 16.9 % of RSL versus 19.9 % of WL had close margins (p = 0.38). The median operative time was longer for lumpectomy and sentinel lymph node biopsy (SLNB) in the RSL group (55 vs. 48 min, p\0.0001). There was no significant difference in the volume of tissue excised between groups. Conclusions. In the first 6 months of RSL, operative scheduling was simplified, while rates of positive and close margins were similar to those seen after many years of experience with WL. Operative time was slightly longer for RSL lumpectomy and SLNB; we anticipate this will decrease with experience.
AB - Background. Wire localization (WL) of nonpalpable breast cancers on the day of surgery is uncomfortable for patients and impacts operating room efficiency. Radioactive seed localization (RSL) before the day of surgery avoids these disadvantages. In this study we compare outcomes of our initial 6-month experience with RSL to those with WL in the preceding 6 months. Methods. Lumpectomies for invasive or intraductal cancers localized with a single 125iodine seed (January-June 2012) were compared with those using 1 wire (July- December 2011). Surgeons and radiologists did not change. Positive and close margins were defined as tumor on ink and tumor B1 mm from ink, respectively. Demographic and clinical characteristics and outcomes were compared between RSL and WL patients. Results. There were 431 RSL and 256 WL lumpectomies performed. Clinicopathologic characteristics did not differ between groups. Most seeds (90 %) were placed before the day of surgery. Positive margins were present in 7.7 % of RSL versus 5.5 % of WL patients, and 16.9 % of RSL versus 19.9 % of WL had close margins (p = 0.38). The median operative time was longer for lumpectomy and sentinel lymph node biopsy (SLNB) in the RSL group (55 vs. 48 min, p\0.0001). There was no significant difference in the volume of tissue excised between groups. Conclusions. In the first 6 months of RSL, operative scheduling was simplified, while rates of positive and close margins were similar to those seen after many years of experience with WL. Operative time was slightly longer for RSL lumpectomy and SLNB; we anticipate this will decrease with experience.
UR - http://www.scopus.com/inward/record.url?scp=84892372779&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84892372779&partnerID=8YFLogxK
U2 - 10.1245/s10434-013-3166-4
DO - 10.1245/s10434-013-3166-4
M3 - Article
C2 - 23943024
AN - SCOPUS:84892372779
SN - 1068-9265
VL - 20
SP - 4121
EP - 4127
JO - Annals of Surgical Oncology
JF - Annals of Surgical Oncology
IS - 13
ER -